Eltern laufen neben Kind, das Skateboard fährt

When our son, an
avid skateboarder
suddenly had balance
and coordination
problem, it became
obvious we weren’t
looking at

let's recode the story

Zwei junge Kinder, die miteinander spielen

We’ll know we’re done recoding when nothing is untreatable

Recoding gives us the opportunity to rewrite stories. Our personal story. The story of medical innovation. The story of disease, treatment, and healthcare. The story we tell ourselves about what’s possible. Because things we may think of as permanent are actually open to reimagining and revising. Whether it’s science, the system, or even the parts of our body that let us down, we have the opportunity to start writing a different ending.

Making a difference starts with taking a stand

At bluebird bio, we’re pushing hard on gene therapy because we believe it delivers the chance for people with severe genetic diseases and cancer to live fully, regardless of what’s written in their DNA. We’re doing the hard work because people facing these challenges deserve it.

Our goal is to recode the science, the system – and even the status quo – for life.

We believe we can unlock the potential for fuller, healthier lives

We are 1,100+ employees across the US & Europe who care deeply and challenge convention to help the people who need us. We are working toward four potential product approvals by 2022 and a pipeline ready to tackle a range of severe diseases. Powered by multiple labs, in-house lentiviral vector manufacturing capabilities and future drug product production, we push ourselves to find answers for the people who need them by exploring the cutting-edge spectrum of gene therapy.

We fly as one and invite like-minded pioneers to join us

We pride ourselves on a unique, caring culture that drives success. A diverse flock of individuals, we still share a common drive that helps us build meaningful relationships with the industry, partners, advocacy groups – and the people who need our help.

We’re building platforms with broad therapeutic potential because incremental improvements won’t do

Recoding the stories of people’s lives requires a different way of treating disease. That’s why we’re all-in on building integrated product platforms that encompass gene therapy, cancer immunotherapy and gene editing. We believe these approaches will provide the potential to treat a broad range of serious conditions – with the goal that people will be able to live their lives fully.
Handgeschriebene Wörter "what we do"